Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 284

Related Citations for PubMed (Select 21790894)

1.

Advances in therapies for acute promyelocytic leukemia.

Kamimura T, Miyamoto T, Harada M, Akashi K.

Cancer Sci. 2011 Nov;102(11):1929-37. doi: 10.1111/j.1349-7006.2011.02045.x. Epub 2011 Aug 24. Review.

PMID:
21790894
2.

Arsenic but not all-trans retinoic acid overcomes the aberrant stem cell capacity of PML/RARalpha-positive leukemic stem cells.

Zheng X, Seshire A, Rüster B, Bug G, Beissert T, Puccetti E, Hoelzer D, Henschler R, Ruthardt M.

Haematologica. 2007 Mar;92(3):323-31.

3.
4.

Acute promyelocytic leukemia: a paradigm for differentiation therapy.

Grimwade D, Mistry AR, Solomon E, Guidez F.

Cancer Treat Res. 2010;145:219-35. doi: 10.1007/978-0-387-69259-3_13. Review.

PMID:
20306254
5.
6.

The design of selective and non-selective combination therapy for acute promyelocytic leukemia.

Jing Y, Waxman S.

Curr Top Microbiol Immunol. 2007;313:245-69. Review.

PMID:
17217047
8.

Comparison of clinical outcomes of patients with relapsed acute promyelocytic leukemia induced with arsenic trioxide and consolidated with either an autologous stem cell transplant or an arsenic trioxide-based regimen.

Thirugnanam R, George B, Chendamarai E, Lakshmi KM, Balasubramanian P, Viswabandya A, Srivastava A, Chandy M, Mathews V.

Biol Blood Marrow Transplant. 2009 Nov;15(11):1479-84. doi: 10.1016/j.bbmt.2009.07.010. Epub 2009 Sep 1.

PMID:
19822309
9.

Transcription therapy for acute promyelocytic leukaemia.

Douer D.

Expert Opin Investig Drugs. 2000 Feb;9(2):329-46. Review.

PMID:
11060680
10.

Current treatment strategy of acute promyelocytic leukemia.

Mi J.

Front Med. 2011 Dec;5(4):341-7. doi: 10.1007/s11684-011-0169-z. Epub 2011 Dec 27. Review.

PMID:
22198746
11.

The expanding role of arsenic in acute promyelocytic leukemia.

Tallman MS.

Semin Hematol. 2008 Jul;45(3 Suppl 2):S25-9. doi: 10.1053/j.seminhematol.2008.07.008. Review.

PMID:
18760708
12.

All-trans retinoic acid/As2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia.

Shen ZX, Shi ZZ, Fang J, Gu BW, Li JM, Zhu YM, Shi JY, Zheng PZ, Yan H, Liu YF, Chen Y, Shen Y, Wu W, Tang W, Waxman S, De Thé H, Wang ZY, Chen SJ, Chen Z.

Proc Natl Acad Sci U S A. 2004 Apr 13;101(15):5328-35. Epub 2004 Mar 24.

13.

What is the role of arsenic in newly diagnosed APL?

Tallman MS.

Best Pract Res Clin Haematol. 2008 Dec;21(4):659-66. doi: 10.1016/j.beha.2008.09.002. Review.

PMID:
19041605
14.

How to manage acute promyelocytic leukemia.

Mi JQ, Li JM, Shen ZX, Chen SJ, Chen Z.

Leukemia. 2012 Aug;26(8):1743-51. doi: 10.1038/leu.2012.57. Epub 2012 Mar 16. Review.

PMID:
22422168
15.

Hypoxia-simulating agents and selective stimulation of arsenic trioxide-induced growth arrest and cell differentiation in acute promyelocytic leukemic cells.

Yan H, Peng ZG, Wu YL, Jiang Y, Yu Y, Huang Y, Zhu YS, Zhao Q, Chen GQ.

Haematologica. 2005 Dec;90(12):1607-16.

16.

Treatment concepts of acute promyelocytic leukemia.

Lengfelder E, Saussele S, Weisser A, Büchner T, Hehlmann R.

Crit Rev Oncol Hematol. 2005 Nov;56(2):261-74. Epub 2005 Oct 19. Review.

PMID:
16236522
17.

Retinoic acid and arsenic trioxide for acute promyelocytic leukemia.

Lo-Coco F, Avvisati G, Vignetti M, Thiede C, Orlando SM, Iacobelli S, Ferrara F, Fazi P, Cicconi L, Di Bona E, Specchia G, Sica S, Divona M, Levis A, Fiedler W, Cerqui E, Breccia M, Fioritoni G, Salih HR, Cazzola M, Melillo L, Carella AM, Brandts CH, Morra E, von Lilienfeld-Toal M, Hertenstein B, Wattad M, Lübbert M, Hänel M, Schmitz N, Link H, Kropp MG, Rambaldi A, La Nasa G, Luppi M, Ciceri F, Finizio O, Venditti A, Fabbiano F, Döhner K, Sauer M, Ganser A, Amadori S, Mandelli F, Döhner H, Ehninger G, Schlenk RF, Platzbecker U; Gruppo Italiano Malattie Ematologiche dell'Adulto; German-Austrian Acute Myeloid Leukemia Study Group; Study Alliance Leukemia.

N Engl J Med. 2013 Jul 11;369(2):111-21. doi: 10.1056/NEJMoa1300874.

18.
19.

Arsenic trioxide as first-line treatment for acute promyelocytic leukemia.

Leu L, Mohassel L.

Am J Health Syst Pharm. 2009 Nov 1;66(21):1913-8. doi: 10.2146/ajhp080342.

PMID:
19850784
20.

Is cytarabine required in the treatment of acute promyelocytic leukemia?

Adès L, Fenaux P.

Curr Hematol Malig Rep. 2006 Jun;1(2):122-5. doi: 10.1007/s11899-006-0023-6. Review.

PMID:
20425342
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk